Position
Creative Planning in Bicara Therapeutics Inc.
Back to the book · All holders of BCAX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $66.8K$16.83 → $19.89
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 21.8K | $367.5K | — | — | — | 0.0% |
| Q1 2026 | 21.8K | $433.9K | $19.89 | $66.8K | −$303 | 0.0% |